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Abstract 38 
Maternal asthma increases the risk of adverse pregnancy outcomes and may affect fetal growth 39 
and placental function by differential effects on the expression of glucocorticoid receptor (GR) 40 
isoforms, leading to altered glucocorticoid signalling. Our aim was to examine the effect of 41 
maternal asthma on placental GR profiles using a pregnant sheep model of asthma. Nine known GR 42 
isoforms were detected. There was a significant increase in the expression of placental GR isoforms 43 
that are known to have low trans-activational activity in other species including GR A, GR P and 44 
GRγ which may result in a pro-inflammatory environment in the presence of allergic asthma.  45 
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Introduction 46 
Asthma is an inflammatory disease that complicates 12% of human pregnancies [1] and associated 47 
with adverse perinatal outcomes including growth restriction and preterm delivery [2, 3] especially 48 
in women with uncontrolled asthma during pregnancy[4]. Changes in fetal growth associated with 49 
maternal asthma may be the result of alterations in placental function and structure with specific 50 
changes in glucocorticoid regulated pathways mediated by differential expression of placental 51 
glucocorticoid receptor (GR) isoforms[5-7] . 52 
 53 
The glucocorticoid receptor (GR) is a ubiquitously expressed protein and a member of the nuclear 54 
receptor transcription factor super family [8-12]. Multiple GR isoforms are present in the placentae 55 
of humans[5, 13], guinea pigs[14] and mice[15] and their abundance varies with glucocorticoid 56 
exposure, pregnancy complications, gestational age and fetal sex. The differential expression of GR 57 
isoforms may confer differences in placental glucocorticoid sensitivity to ensure fetal survival in an 58 
adverse maternal environment. We developed a pregnant sheep model of maternal allergic asthma 59 
that causes physiological changes in the maternal lung comparable to human asthma, reduces fetal 60 
growth and changes fetal lung development [16].  We aimed to identify whether the sheep placenta 61 
expresses multiple GR isoforms and if expression is altered by the presence of maternal allergic, 62 
asthma. 63 
 64 
 65 
 66 
  67 
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Methods  68 
Experimental procedures were approved by the Animal Ethics Committees of Monash University 69 
(MARP/2013/133) and the University of Adelaide (M-2014-126).  The breeding and treatment 70 
protocol for allergic, asthmatic (induced by house dust mite) (n = 7) or control (n = 5) singleton 71 
bearing Merino ewes (1-2 years of age) are reported in Clifton et al[16]. All placentomes were 72 
removed from the endometrium at term delivery, individually weighed and classified for phenotype 73 
(Type A, B, C or D)[17]. Frozen whole placentome samples of each phenotype from control and 74 
asthmatic sheep were crushed and tissue was fractionated into cytosolic and nuclear components 75 
[5]. The volume density of placental tissue was quantified in formalin fixed sections of each 76 
phenotype from control and asthmatic sheep[18, 19]. The surface area and barrier thickness were 77 
calculated using the weight of the individual placentome or total placental weight. GR isoforms 78 
were identified and visualised by Western blot using an affinity purified polyclonal rabbit anti-79 
human total GR antibody (1:1000) (Bethyl Laboratories, Montgomery, TX, USA, A303-491A). The 80 
antibody is reactive to sheep antigens (Bethyl Lab website).  A specific GR β antibody (1:1000) was 81 
also used (Abcam Cambridge, MA, USA) [5]. Densitometry was used to quantify GR expression 82 
and normalised against β-actin[5]. Lamin A/C was used to ensure cytosolic fractions were clear of 83 
nuclear proteins[5]. Peptide pre-absorption was also conducted as an antibody specificity control 84 
using rabbit anti-human-GR total (1:1200) incubated with 10:1 concentration of control peptide 85 
(Bethyl Laboratories). Data analysed by Mann Whitney U test and Spearman’s correlations using 86 
SPSS 22.0 for Windows (IBM, Armonk, USA). 87 
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Results  
Maternal, neonatal and placental characteristics  
Maternal plasma cortisol concentrations were decreased in pregnancies complicated by allergic asthma 
(Table 1). As previously published, fetal weight relative to maternal body weight was decreased in 
pregnancies complicated by asthma (n = 7) compared to control (n = 5) (p = 0.038). The proportion of 
Type-B and -C placentomes (%) was higher in pregnancies complicated by asthma compared to control 
(p = 0.037, p = 0.047, respectively)[16].  Placental volumes were reduced in asthmatic ewes (Table 2).  
 
GR isoforms expressed in the ovine placenta 
Thirteen bands were identified in cytosolic and nuclear protein extractions from sheep placentomes (n 
= 45) at molecular weights of 40 to107 kDa (Fig. 1). GR peptide pre-absorption resulted in the 
inhibition of all bands specific to GR antibody (data not shown). Nine protein bands correspond to GRγ 
(95 kDa), GRα-A (94kDa), GRβ (91 kDa), GRα-C1-3 (81-83 kDa), GR-P (70 kDa), GR-A (65 kDa) 
and GRα-D1-3 (50-55 kDa). The 91 kDa band was confirmed to be GRβ using a specific antibody.  
GR-A, GR-D2, GR-D3 and 45 kDa protein were the most abundant isoforms.  
 
Effect of asthma and placentome type on GR isoform expression 
Type-A placentomes from pregnancies complicated by asthma had higher expression of nuclear GRα-
C1-3, GR-A and GRα-D1 relative to control (Mann-Whitney U Test P=0.038) (Fig. 2). Type-B 
placentomes from asthmatic ewes had higher cytosolic and nuclear GRγ expression (P = 0.048, P = 
0.024, respectively), higher cytosolic expression of GRα-A (p = 0.03) and GR-P (p = 0.048) (Fig. 2). 
There was higher expression of some of the unidentified GRs in Type B placentomes of asthmatic ewes 
relative to control, which included higher 48 kDa (p = 0.018), 45 kDa (p = 0.018) and nuclear 
expression of 68/69 kDa (p = 0.024) (data not shown). There were no significant differences in GR 
isoform expression between groups in Type-C placentomes (data not shown). Cytosolic GRα-A (p = 
0.024) expression was higher in Type-D placentomes of asthmatic ewes (Fig. 2). 
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Discussion  
Multiple isoforms of the GR are expressed in the sheep placenta and their levels were altered by the 
maternal allergic asthma. GR isoforms were also expressed differently in morphologically classified 
placentome types. GR expression has been previously reported in multiple organs of the ovine fetus 
including the placenta[20] but those studies only examined expression of GRα A and GRβ. Our study 
is the first to show there are 13 GR-immunoreactive proteins and demonstrate that the placental GR 
profile in the sheep is similar to the placenta of humans [5] and other animals[14, 15] suggesting 
multiple GR isoforms are conserved across species. Multiple GR isoforms, expressed in many different 
combinations, may ensure only specific placental glucocorticoid-regulated genes are activated or 
repressed under different physiological conditions such as the presence of maternal asthma. 
The low trans-activational GR isoforms; GR P, GRγ and GRα D1, all associated with 
glucocorticoid resistance in humans [21], and GRα C, known to mediate glucocorticoid-induced 
apoptosis[21], were localised to sheep placental nuclei suggesting downstream inflammatory pathways 
and apoptotic mechanisms may predominate in the presence of asthma. It appears that in the presence 
of maternal asthma, the ovine placenta adapts by reducing its glucocorticoid responsiveness. Previous 
work in pregnant women have identified sex differences in the placental response to maternal 
asthma[7] so further studies are required to assess the effect of sex in this experimental model. Our 
studies establish the value of our sheep model of maternal asthma in pregnancy for understanding the 
impact of maternal asthma on pregnancy.  
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Figure legend 
 
Figure 1: A: Sheep placentome glucocorticoid receptor isoforms of control pregnancies 
and pregnancies complicated by maternal allergic asthma Glucocorticoid receptor 
isoforms were measured in cytoplasmic and nuclear fractions of whole A, B, C and D type 
placentomes. Human placental tissue was used as a positive control. Blot is representative is 
of placental tissues from control (top) and asthmatic (bottom) animals. GR protein bands 
were normalised to β-Actin and LaminA/C was used to ensure nuclear fraction was specific.  
B. Sheep placentome glucocorticoid receptor isoform expression of pregnancies 
complicated by maternal allergic asthma in placentomes A, B and D.   GR isoforms were 
significantly altered in A, B and D placentomes.   The left panel shows isoforms that changed 
in the cytosolic fractions and the right panel shows isoforms that changed in the nuclear 
fractions of whole placentome extracts. Data is expressed as median with 25th-75th quartile 
range. The white bars are the controls group and the shaded bars are the asthmatic group. 
Significance was P <0.05 
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Values displayed are means ± standard error of the mean. Significance P<0.05. 
Control Asthma p
n 5 7
Maternal Characteristics
Post mortem weight (kg) 38.86 ± 2.07 39.60 ± 1.41 n.s.
Gestational age (days) 140.00 ± 1.10 139.57 ± 0.53 n.s.
Neonatal Characteristics
Body weight (kg) 4.11 ± 0.28 3.69 ± 0.14 n.s.
Fetal: Maternal weight 0.11 ± 0.01 0.09 ± 0.00 0.038
Placenta characteristics
Placental weight (g) 343.75 ± 50.98 322.90 ± 23.32 n.s.
 Type-A placentome
        Proportion of placentomes (%) 49.42 21.05 n.s.
         Average weight (g) 3.93 ± 0.58 3.46 ± 0.55 n.s.
Type-B placentome
        Proportion of placentomes (%) 22.59 45.95 0.037
         Average weight (g) 4.18 ± 0.72 4.23 ± 0.25 n.s.
Type-C placentome
        Proportion of placentomes (%) 7.56 18.86 0.047
         Average weight (g) 4.32 ± 1.07 3.97 ± 0.26 n.s.
Type-D placentome
        Proportion of placentomes (%) 20.43 14.15 n.s.
         Average weight (g) 4.31 ± 1.01 5.38 ± 0.62 n.s.
Trophoblast volume density (Vd)
Vd 0.527 ± 0.009 0.525 ± 0.006 n.s.
Volume of placenta (cm3) 213.876 ± 11.908 169.990 ± 5.905 0.0008
Fetal capillaries volume density (Vd)
Vd 0.008 ± 0.001 0.007 ± 0.001 n.s.
Volume of placenta (cm3) 3.154 ± 0.263 2.395 ± 0.230 n.s.
Fetal connective tissue volume density (Vd)
Vd 0.062 ± 0.005 0.057 ± 0.002 n.s.
Volume of placenta (cm3) 24.726 ± 1.509 18.392 ± 0.828 0.0004
Maternal epithelium volume density (Vd)
Vd 0.185 ± 0.006 0.191 ± 0.003 n.s.
Volume of placenta (cm3) 74.897 ± 4.545 61.153 ± 1.829 0.0016
Maternal capillaries volume density (Vd)
Vd 0.019 ± 0.001 0.016 ± 0.001 n.s.
Volume of placenta (cm3) 7.687 ± 0.549 5.290 ± 0.405 0.0027
Maternal connective tissue volume density (Vd)
Vd 0.200 ± 0.007 0.204 ± 0.004 n.s.
Volume of placenta (cm3) 80.327 ± 3.483 65.751 ± 2.208 0.0013
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Highlights 
Sheep placenta contains 9 different glucocorticoid receptor (GR) isoforms 
GR isoform expression varies in relation to placentome type 
Low transactivational GR isoforms predominate in the presence of a sheep model of maternal 
allergic asthma 
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